Avella Specialty Pharmacy began as a single pharmacy in Scottsdale, Arizona in 1996. It has since expanded to become one of the fastest-growing healthcare companies in the nation, licensed in all 50 states with 2 central fill, 9 retail, and 2 503(b) compounding sites. Through it all, Avella has stayed true to our steadfast vision: facilitating a hands-on, patient and physician focused approach to the dynamic and growing arena of specialty pharmaceuticals. The ASHP-APhA accredited PGY1 Community Pharmacy Residency is a 12-month post-graduate program designed to provide a unique community practice environment to help develop expertise in Specialty Pharmacy.
The residency program is based at the National Distribution Center headquarters in Phoenix, Arizona, with mild temperatures year-round that allow for sports, dining, festivals and outdoor activities nearly year round. This site offers a variety of patient care services to support chronic, complex specialty disease states such as: Oncology, Hepatitis C, HIV, Autoimmune (Rheumatoid Arthritis, Psoriasis, Crohn's Disease, Ulcerative Colitis and Lupus), Asthma, Pain and Fertility. Residents will work with clinical pharmacists, manufacturers, third party payors and other healthcare professionals to manage patient medication therapy and help to improve patient outcomes.
Learning experiences include: Specialty Patient Care, Specialty Pharmacy Management (Managed Care, Industry, Regulatory and Executive), Staffing, rural HIV Ambulatory Clinic, Teaching (including teaching an elective class, working with APPE rotation interns, and obtaining a teaching certificate) and a Research Project.
Avella Specialty Pharmacy provides postgraduate training to pharmacists with a focus in specialty pharmacy to implement and expand existing clinical patient services, develop strategies for specialty pharmacy business and to become leaders within the pharmacy profession. The purpose of this PGY1 community residency is to prepare pharmacist clinician graduates to apply for specialty clinical patient care or business positions or pursue PGY2 training in an area of a specialty disease state.
Candidates must be a graduate from an accredited College of Pharmacy and eligible for Arizona licensure.
Interested candidates should apply online through the Pharmacy Online Residency Centralized Application Service (PhORCAS) and include the following:
Letter of Interest
Three Letters of Recommendation
About Avella Specialty Pharmacy
Avella is a national specialty pharmacy dedicated to empowering patients, providers and other organizations across the entire healthcare continuum. We are invested in improving the health—and the lives—of the people we serve. We accomplish this goal by acting as expert clinicians, passionate advocates, committed healthcare partners and strategic innovators.
Avella provides a level of service and support that is rarely seen today. Our patient satisfaction rate is more than just a metric—it is a reflection of our commitment to caring for patients on their terms. We consistently hear from patients that we are “remarkable” “extraordinary” and “make a difference” in their lives. We earn these accolades by striving to respect each individual’s time, address their concerns about treatment and support their emotional well-being.
Yet we also employ the leading technology of tomorrow to complement, and not replace, our high-touch approach.
This includes mobile apps, a provider portal and smart pill bottles designed to improve care and create a better patient and provider experience.
Our staff collaborate with providers, drug manufacturers and payers to guide patients through every... step of their treatment— from securing prior authorization to product fulfillment and mid-therapy support. Our pharmacists can work with providers at a peer-to-peer level thanks to their deep disease state knowledge in specialties like oncology, pain and addiction management, infectious diseases and many other complex, chronic conditions.
Avella is actively improving access to care through our powerful specialty medications, including 50-plus limited distribution drugs, as well as compounded therapies created in our state-of-the-art clean rooms.